Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation

INTRODUCTION: Direct current cardioversion (DCCV) is considered as the most effective treatment for atrial fibrillation (AF). AF is associated with an increased risk of thromboembolism, and DCCV may increase this risk. The current recommendation is, therefore, to anticoagulate for at least 3 weeks b...

Descripción completa

Detalles Bibliográficos
Autores principales: Benamer, Sufyan, Lusty, Debbie, Everington, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125109/
https://www.ncbi.nlm.nih.gov/pubmed/27457612
http://dx.doi.org/10.1007/s40119-016-0067-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125109/
https://www.ncbi.nlm.nih.gov/pubmed/27457612
http://dx.doi.org/10.1007/s40119-016-0067-1

Ejemplares similares